Adverum Biotechnologies Appoints Linda Neuman, M.D. as Vice President, Clinical Development

Go back to Adverum Biotechnologies Appoints Linda Neuman, M.D. as Vice President, Clinical Development
(NASDAQ: ADVM) Delayed: 4.36 --0 (-0%)
Previous Close $4.36    52 Week High $4.86 
Open $4.36    52 Week Low $2.74 
Day High $4.36    P/E N/A 
Day Low $4.36    EPS $0.00 
Volume 6,744